Subsequently, a study in 2022 found that the decrease in PON1 activity would participate in the occurrence of psychotic disorders (including psychosis, anxiety, depression, etc.)by increasing oxidative stress in patients with TLE and MTS comorbid with mental disorders [159]. This evidence concerns the gene PON1 and psychotic disorder.